Kexing Biopharm Co., Ltd. (688136.SS) SHH
29.49
-0.4(-1.34%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
29.49
-0.4(-1.34%)
Currency In CNY
| Market Cap | 6.23B |
| Enterprise Value | 6.23B |
| P/E Ratio | 35.38 |
| PEG Ratio | 1.24 |
| Price/Sales Ratio | 3.79 |
| Price/Book Ratio | 3.29 |
| Enterprise/Revenue | 4.38 |
| Enterprise/EBITDA | 26.41 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | 0.1 |
| Operating Margin | 0.11 |
| Return On Assets | 0.05 |
| Return On Equity | 0.1 |
| Revenue | 1.54B |
| Revenue/Share | 8.06 |
| Gross Profit | 1.54B |
| EBITDA | 255.5M |
| Net Income | 159.44M |
| Diluted EPS | 0.81 |
| Total Cash | 612.79M |
| Total Cash/Share | 3.2 |
| Total Debt | 1.4B |
| Total Debt/Equity | 0.82 |
| Current Ratio | 1.5 |
| Book Value Per Share | 8.97 |
| 52-Week Change | 44.99 |
| 52-Week High | 63.99 |
| 52-Week Low | 20.07 |
| Moving Average 50 Days | 31.86 |
| Moving Average 200 Days | 38.52 |
| Average Volume | 2.69M |
| Shares Outstanding | 198.11M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.08 |
| Trailing Annual Dividend Yield | 0.27 |
| Payout Ratio | 0.29 |
| Last Split Factor | N/A |
| Last Split Date | N/A |